Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$130.81
-0.4%
$129.71
$99.71
$141.23
$226.87B0.75.86 million shs6.71 million shs
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
$555.66
-2.0%
$589.61
$493.86
$613.23
$589.00B1.0152.75 million shs71.04 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+4.12%+3.91%-3.21%+14.50%+16.04%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
-0.27%+0.28%-4.57%-4.69%+8.39%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8386 of 5 stars
2.44.02.54.54.12.52.5
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.945.45% Upside
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
2.71
Moderate Buy$555.54-0.02% Downside

Current Analyst Ratings Breakdown

Latest SPY and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $154.00
1/28/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
1/27/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$149.00 ➝ $158.00
1/23/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$130.00 ➝ $135.00
1/23/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$133.00 ➝ $136.00
1/23/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$146.00 ➝ $148.00
1/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$135.00 ➝ $135.00
1/2/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$136.00
(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.41$5.63 per share23.22$22.36 per share5.85
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6517.1022.832.5231.95%20.74%11.19%4/16/2025 (Estimated)
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/A24.94N/AN/AN/AN/AN/A

Latest SPY and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.80%N/A30.85%N/A
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
$7.071.27%N/AN/AN/A

Latest SPY and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
63.54%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/A1.06 billionN/ANot Optionable

Recent News About These Companies

TDVG Combines Benefits of Active Management, Dividends
July 22, 2024, Paraguay. In this photo illustration, the Meta Platforms, Inc. logo is displayed on a smartphone screen — Stock Editorial Photography
The 5 Most Oversold Stocks on the Market Are…  (SPY)
SPY ETF News, 3/27/2025
Following UBS Analysts? Tap These ETF Strategies
How To Trade SPY Today: A Technical Perspective
World Markets Watchlist: March 24, 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$130.81 -0.54 (-0.41%)
Closing price 03:59 PM Eastern
Extended Trading
$130.66 -0.15 (-0.11%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

SPDR S&P 500 ETF Trust stock logo

SPDR S&P 500 ETF Trust NYSEARCA:SPY

$555.66 -11.42 (-2.01%)
Closing price 04:10 PM Eastern
Extended Trading
$554.27 -1.39 (-0.25%)
As of 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products.